Employment Verification for Cardiovascular Systems.

About Cardiovascular Systems

Cardiovascular Systems, Inc. (CSI) is a Minnesota-based medical technology company that specializes in developing and commercializing minimally invasive treatments for arterial diseases. The company’s patented orbital atherectomy systems are designed to treat a range of conditions, including peripheral artery disease (PAD), which affects millions of Americans. CSI was founded in 1989 by Dr. David L. Martin, a cardiovascular surgeon, with the goal of developing a safer, more effective treatment for arterial disease. The company’s first product, the Diamondback 360® System, was approved by the FDA in 2007 and has since become the leading orbital atherectomy system on the market. In addition to its flagship product, CSI also offers a range of specialty catheters and accessories to support its orbital atherectomy systems. The company’s products are used by physicians in clinics and hospitals across the United States and around the world. While CSI focuses on the treatment of peripheral artery disease, the company has also developed a range of products for other cardiovascular conditions, including the Stealth 360® Peripheral Orbital Atherectomy System for treating calcified coronary lesions. With a commitment to innovation and patient care, CSI continues to push the boundaries of minimally invasive treatments for cardiovascular disease.

The information on this page is not an endorsement of Truv’s services by Cardiovascular Systems and is meant to be purely informational.

Verify Cardiovascular Systems Employees

Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee, learn more.